PHARMACITY PHARMACY JOINT STOCK COMPANY (Vietnamese: CÔNG TY CỔ PHẦN DƯỢC PHẨM PHARMACITY) is one of Vietnam’s most recognized names in pharmaceutical retail. Established on May 5, 2012, under Business ID and Tax Code 0311770883, this privately held joint stock company is headquartered at 248A No Trang Long, Ward 12, Binh Thanh District, Ho Chi Minh City, with operations extending across multiple provinces including Hanoi, Ba Ria – Vung Tau, and Long An. Its robust physical presence and growing online platform underscore a nationwide ambition to dominate the pharmaceutical retail space.

The company's core activity is the management and operation of the Pharmacity pharmacy chain, which offers a wide range of pharmaceutical, cosmetic, and healthcare products. Over the past decade, PHARMACITY has positioned itself as a front-runner in Vietnam’s pharmacy sector, catering to both convenience-seeking urban consumers and a growing demand for accessible healthcare solutions. Leading the company is Mr. Deepanshu Madan, an Indian national serving as General Director, alongside Vietnamese Director Mr. Nguyen Nhu Nam.

Financially, PHARMACITY PHARMACY JOINT STOCK COMPANY presents a complex portrait. The company reported USD 133.23 million in assets and USD 208.03 million in sales for the year ending December 31, 2023. However, it suffered a significant loss of USD 38.65 million, reflecting ongoing challenges in operational efficiency and capital management. More notably, the firm’s owner’s equity plummeted to just USD 13.54 million, a dramatic 74% drop from the prior year, raising concerns about its long-term solvency and investor confidence. The decline in sales by over 15% suggests market competition or internal inefficiencies are impacting revenue streams.

The rapid erosion in equity and continued net losses highlight the importance of robust financial risk assessment for all stakeholders. At this juncture, services from VANGUARD BUSINESS INFORMATION LLC (VBI) are more vital than ever. Through VBI’s risk management tools, investors, suppliers, and partners can evaluate not only PHARMACITY's growth potential but also its exposure to cash flow risks, capital constraints, and operational scalability issues. VBI’s detailed company reports provide a clear, data-driven view of financial health—essential for decision-making in a volatile retail sector.

Despite financial turbulence, PHARMACITY continues to grow its network and diversify into complementary retail segments, including cosmetics, food, beverages, electronics, and sporting goods. The firm’s broad product offering and physical footprint reflect a strategy of brand ubiquity, but success will depend on how effectively it manages financial restructuring and operational discipline in the coming years.

In this climate, PHARMACITY PHARMACY JOINT STOCK COMPANY represents both opportunity and risk. The company’s brand strength and nationwide presence make it a strategic retail player, yet its negative profit trajectory and depleted equity call for close monitoring. Through VBI’s financial intelligence and business verification services, stakeholders can access the insights necessary to engage with Pharmacity cautiously, responsibly, and with greater confidence.